Iron Status of Non-anemic Pregnant Women in First Trimester

Launched by HUNG VUONG HOSPITAL · May 18, 2025

Keywords

ClinConnect Summary

This clinical trial is studying iron levels in pregnant women who are not anemic, specifically during their first trimester. The goal is to find out what normal iron levels are for healthy pregnant women and to see how common iron deficiency is in this group. By collecting information on various iron markers in the blood, the study aims to create a reliable reference for doctors to use when checking for iron deficiency early on in pregnancy.

To be eligible to participate, women need to be pregnant with one baby and attending regular prenatal care. They should have normal blood pressure and body temperature, and their hemoglobin levels (a measure of red blood cells) should be at least 11 g/dL. However, women with certain health conditions, like diabetes or gastrointestinal diseases, or those taking specific medications will not be able to join the study. Participants can expect to undergo tests that measure their iron levels, which will help improve understanding of iron needs during pregnancy.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Pregnant women attending antenatal care, carrying a single live fetus.
• • Systolic blood pressure at the time of examination \< 140 mmHg.
• • Diastolic blood pressure at the time of examination \< 90 mmHg.
• • Body temperature at the time of examination between \>35°C and \<37.5°C.
• • Hemoglobin ≥ 11 g/dL
• Exclusion Criteria:
• • History of diabetes mellitus, hypertension, hemoglobinopathies, leukemia, non-hematologic cancers, systemic lupus erythematosus, Gastrointestinal diseases (Celiac disease, Crohn's disease and ulcerative colitis, Gastric diseases or prior gastrointestinal surgery, Irritable bowel syndrome, etc).
• • Currently on gastric acid-suppressing medications: Proton pump inhibitors (e.g., Omeprazole, Lansoprazole, Esomeprazole...), H2 receptor antagonists (e.g., Ranitidine, Famotidine, Cimetidine...), Positive screening for Treponema pallidum, HBsAg, or HIV.
• • Use of stimulants or tobacco smoking.